Linda Schmidt

652 total citations
22 papers, 403 citations indexed

About

Linda Schmidt is a scholar working on Molecular Biology, Hematology and Infectious Diseases. According to data from OpenAlex, Linda Schmidt has authored 22 papers receiving a total of 403 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Hematology and 3 papers in Infectious Diseases. Recurrent topics in Linda Schmidt's work include Multiple Myeloma Research and Treatments (7 papers), Protein Degradation and Inhibitors (4 papers) and Autoimmune Bullous Skin Diseases (3 papers). Linda Schmidt is often cited by papers focused on Multiple Myeloma Research and Treatments (7 papers), Protein Degradation and Inhibitors (4 papers) and Autoimmune Bullous Skin Diseases (3 papers). Linda Schmidt collaborates with scholars based in United States, Slovakia and Germany. Linda Schmidt's co-authors include Ted B. Taylor, Christopher Hull, John J. Zone, Laurence Meyer, Harry R. Hill, Troy D. Jaskowski, Gerald G. Krueger, Michael Kwan, Jeffrey R. Morgan and Marta J. Petersen and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

Linda Schmidt

21 papers receiving 374 citations

Peers

Linda Schmidt
Linda Schmidt
Citations per year, relative to Linda Schmidt Linda Schmidt (= 1×) peers Monika Bowszyc‐Dmochowska

Countries citing papers authored by Linda Schmidt

Since Specialization
Citations

This map shows the geographic impact of Linda Schmidt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linda Schmidt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linda Schmidt more than expected).

Fields of papers citing papers by Linda Schmidt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linda Schmidt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linda Schmidt. The network helps show where Linda Schmidt may publish in the future.

Co-authorship network of co-authors of Linda Schmidt

This figure shows the co-authorship network connecting the top 25 collaborators of Linda Schmidt. A scholar is included among the top collaborators of Linda Schmidt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linda Schmidt. Linda Schmidt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nain, Anil Kumar, et al.. (2024). Crystal Chemical Parameters for the Eu(II) Luminescence in Solid-State Metal Hydrides. Chemistry of Materials. 36(22). 11210–11216.
2.
Schmidt, Linda, Jaeil Ahn, Scott D. Rowley, et al.. (2019). Elotuzumab As Post-Autologous Stem Cell Transplant Consolidation in Patients with High-Risk Myeloma. Blood. 134(Supplement_1). 3141–3141. 2 indexed citations
3.
Jeyapalina, Sujee, John S. Colombo, James P. Beck, et al.. (2019). Epidermal growth factor receptor genes are overexpressed within the periprosthetic soft‐tissue around percutaneous devices: A pilot study. Journal of Biomedical Materials Research Part B Applied Biomaterials. 108(2). 527–537. 2 indexed citations
4.
Biran, Noa, et al.. (2017). Real-world outcomes with panobinostat in patients with penta- and quad-refractory multiple myeloma.. Journal of Clinical Oncology. 35(15_suppl). e19522–e19522. 2 indexed citations
5.
Bilotti, Elizabeth, David H. Vesole, Laura McBride, et al.. (2016). Vorinostat in Combination With Lenalidomide and Dexamethasone in Lenalidomide-Refractory Multiple Myeloma. Clinical Lymphoma Myeloma & Leukemia. 16(10). 558–562. 4 indexed citations
6.
Carlson, Noel G., Linda Schmidt, Thomas P. Huecksteadt, et al.. (2015). The role of the prostaglandin E2 receptors in vulnerability of oligodendrocyte precursor cells to death. Journal of Neuroinflammation. 12(1). 101–101. 9 indexed citations
7.
Schmidt, Linda, et al.. (2015). Prostaglandin F Receptor Mediates Oligodendrocyte Precursor Injury/Death: Potential Role in Multiple Sclerosis (P5.210). Neurology. 84(14_supplement). 1 indexed citations
8.
Zone, John J., Linda Schmidt, Ted B. Taylor, et al.. (2011). Dermatitis Herpetiformis Sera or Goat Anti–Transglutaminase-3 Transferred to Human Skin-Grafted Mice Mimics Dermatitis Herpetiformis Immunopathology. The Journal of Immunology. 186(7). 4474–4480. 44 indexed citations
9.
Hoeven, Karen H. van, Laura McBride, Elizabeth Bilotti, et al.. (2011). The Anion Gap and Routine Serum Protein Measurements in Monoclonal Gammopathies. Clinical Journal of the American Society of Nephrology. 6(12). 2814–2821. 9 indexed citations
10.
Bilotti, Elizabeth, Laura McBride, Linda Schmidt, et al.. (2011). Salvage Therapy with Vorinostat, Lenalidomide, and Dexamethasone (ZRD) in Lenalidomide/Dexamethasone Relapsed/Refractory Multiple Myeloma,. Blood. 118(21). 3986–3986. 9 indexed citations
11.
Hull, Christopher, Lutz Meyer, Linda Schmidt, et al.. (2008). Elevation of IgA anti-epidermal transglutaminase antibodies in dermatitis herpetiformis. British Journal of Dermatology. 159(1). 120–124. 60 indexed citations
12.
Zone, John J., Ted B. Taylor, Christopher Hull, Linda Schmidt, & Laurence Meyer. (2007). IgE Basement Membrane Zone Antibodies Induce Eosinophil Infiltration and Histological Blisters in Engrafted Human Skin on SCID Mice. Journal of Investigative Dermatology. 127(5). 1167–1174. 84 indexed citations
13.
Rallis, Tena M., et al.. (1997). Expression of c‐fos in cultured human nevus cells: an increase over melanocytes and melanoma cells. Experimental Dermatology. 6(6). 308–313. 2 indexed citations
14.
Meyer, Laurence J., Linda Schmidt, David E. Goldgar, & Michael W. Piepkorn. (1995). Survival and Histopathologic Characteristics of Human Melanocytic Nevi Transplanted to Athymic (Nude) Mice. American Journal of Dermatopathology. 17(4). 368–373. 2 indexed citations
15.
Petersen, Marta J., Jerry Kaplan, Linda Schmidt, et al.. (1995). Sustained Production of Human Transferrin by Transduced Fibroblasts Implanted into Athymic Mice: A Model for Somatic Gene Therapy. Journal of Investigative Dermatology. 104(2). 171–176. 22 indexed citations
16.
Krueger, Gerald G., Jeffrey R. Morgan, Linda Schmidt, et al.. (1994). Genetically Modified Skin to Treat Disease: Potential and Limitations.. Journal of Investigative Dermatology. 103(s5). 76S–84S. 36 indexed citations
17.
Krueger, Gerald G., Jeffrey R. Morgan, Linda Schmidt, et al.. (1994). Genetically Modified Skin to Treat Disease: Potential and Limitations. Journal of Investigative Dermatology. 103(5). 76–84. 46 indexed citations
18.
Schmidt, Linda, et al.. (1991). Improvements in detection of antibody to hepatitis B core antigen by treating specimens with reducing agent in an automated microparticle enzyme immunoassay. Journal of Clinical Microbiology. 29(3). 611–616. 13 indexed citations
19.
Stites, Daniel P., George Brecher, Linda Schmidt, & F. M. Berger. (1979). Suppressive effects of chlorphenesin on lymphocyte function in mice and humans. Immunopharmacology. 2(1). 39–49. 2 indexed citations
20.
Hanna, L., Linda Schmidt, Margaret Sharp, D P Stites, & Ernest Jawetz. (1979). Human cell-mediated immune responses to chlamydial antigens. Infection and Immunity. 23(2). 412–417. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026